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Summary 
In contrast to normal microvessels, those that supply tumors are strikingly hyperpermeable to 
circulating macromolecules such as plasma proteins. This leakiness is largely attributable to a tu- 
mor-secreted  cytokine,  vascular permeability factor  (VPF).  Tracer  studies  have  shown  that 
macromolecules cross tumor vascular endothelium by way of a recently described cytoplasmic 
organelle, the vesiculo-vacuolar organelle or WO  (WOs  are grapelike clusters of intercon- 
nected, uncoated vesicles and vacuoles). However, equivalent VVOs are also present in the cy- 
toplasm of normal venules that do not leak substantial amounts of plasma protein. To explain 
these findings, we hypothesized that VPF increased the permeability of tumor blood vessels by 
increasing VVO function and that the WOs  of normal venules were relatively impermeable in 
the absence of VPF stimulation. To test this hypothesis, VPF was injected intradermally in nor- 
real animals after intravenous injection of a soluble macromolecular tracer, ferritin, whose ex- 
travasation could be followed by electron microscopy. VPF caused normal venules to leak fer- 
ritin,  and,  as  predicted  by our hypothesis,  ferritin  extravasated by way  of WOs,  just  as in 
hyperpermeable tumor microvessels. Ultrathin (14-nm) serial electron microscopic sections and 
computer-aided three-dimensional reconstructions better defined VVO structure. VVOs occu- 
pied  16-18%  of endothelial  cytoplasm in normal venules.  Individual VVOs were clusters of 
numerous  (median,  124)  interconnected vesicles and vacuoles that formed complex pathways 
across venular  endothelium  with  multiple  openings to both luminal  and  abluminal surfaces. 
Like VPF, histamine and serotonin also stimulated ferritin extravasation across venules by way 
of VVOs. Together, these data establish VVOs as the major pathway by which soluble plasma 
proteins exit venules in response to several mediators that increase venular hyperpermeability. 
These same mediators also increased the extravasation of colloidal carbon, but this large partic- 
ulate nonphysiological tracer exited venules primarily through endothelial gaps. 
M 
ammals  and  other  vertebrates  supply  their  tissues 
with nutrients and clear waste products by means of 
the  "exchange  vessels" of the  microcirculation,  primarily 
the  capillaries  and  postcapillary  venules  (1-5).  Normally, 
the vast majority of transport occurs across capillaries, thin 
vessels that are considerably more numerous than venules 
and that provide a much greater total surface area for mo- 
lecular passage.  Gases, hydrophobic species, and small hy- 
drophilic  molecules  cross  capillaries  rapidly  and  without 
significant impedance;  however,  extravasation of circulat- 
ing  macromolecules  is  highly  restricted  and  only  small 
amounts of plasma proteins cross the endothelial barrier. 
This work was presented in part at the annual meeting of the American 
Society for Cell Biology  in Washington, D.C. on Dec. 12, 1995. Portions of 
this work have appeared  in abstract form (1995. Mol. Biol. Cell. 6:335a). 
A  very different situation prevails in tumors where mi- 
crovessels  are  hyperpermeable  to  plasma proteins  (6,  7). 
This hyperpermeability is largely attributable to the secre- 
tion by tumors of a cytokine, vascular permeability factor 
(VPF 1, also known as vascular endothelial growth factor or 
VEGF) that increases microvascnlar permeability to macro- 
molecules with a potency some 50,000 times that of hista- 
mine.  By  using  suitable  tracers,  macromolecules  were 
found to extravasate across tumor vascular endothelium by 
way  of a  previously unrecognized  cytoplasmic  organeUe, 
the  vesiculo-vacuolar  organelle  or  VVO  (8).  VVOs  are 
grapelike clusters  of uncoated vesicles and vacuoles inter- 
connected by stomata that may be open or are closed by 
1Abbreviations used in this paper: VPF, vascular permeability  factor; WO, 
vesiculo-vacuolar  organeUe. 
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in tumor microvessels have now also been identified in the 
postcapillary venules of several normal tissues (8). 
Taken  together,  these  findings  suggested  that  tumor 
cell--secreted VPF rendered rumor microvascular endothe- 
lium  hyperpermeable by  activating VVO  function.  If so, 
VPF  might  be  expected  to  activate  the  function  of the 
VVOs that are present in normal venular endothelium. To 
test this hypothesis, we injected recombinant human  VPF 
into the skin of normal animals of several species and deter- 
mined the pathways by which a  circulating plasma protein 
tracer, ferritin, crossed the vascular endothelium. In parallel 
experiments,  vascular  permeability  was  enhanced  locally 
with histamine or serotonin in order to determine whether 
inflammatory mediators might also upregulate VVO  func- 
tion. Finally, colloidal carbon was used as a tracer to deter- 
mine if circulating large particulates also exited venules by 
way of VVOs in response to VPF or inflammatory mediators. 
Materials and Methods 
Venular  permeability was  measured  in  young  adult Hartley 
guinea pigs of either sex (Elm Hill, Chelmsford, MA), female A/J 
mice (The Jackson Laboratory, Bar Harbor, ME), or male Sprague- 
Dawley rats  (Charles River, Wilmington, MA).  Flank skin was 
shaved (guinea pigs flanks were also depilated) 1 d before experi- 
mentation. Animals were lightly anesthetized (guinea pigs with 
ketamine and xylazine, mice with tribromoethanol, and rats with 
pentabarbital) immediately before i.v. injection of ferritin (0.5-1 
mg/g;  Sigma Chemical Co.,  St.  Louis,  MO)  or colloidal carbon 
(1.0 ml/250 g; Guenther Wagner, Hannover, Germany). Ferritin is 
a soluble anionic protein of-'~l 1 nm diameter; individual femtin 
molecules are readily visualized by conventional transmission  elec- 
tron microscopy. Normally present in plasma at low levels, fer- 
ritin is cleared slowly and serves as a useful marker for following 
bulk transport extravasation of plasma proteins (8). Colloidal car- 
bon is a suspension of particles of mean diameter N50 nm. 
Immediately after i.v, tracer injection, 0.1 ml recombinant hu- 
man VPF (5-100 ng, Peprotech, tLocky Hill, NJ), histamine, se- 
rotonin (both 1 t~g, Sigma Chemical Co.), or HBSS was injected 
intradermally at different sites on flank or scrotal skin and animals 
were killed 10 s-30 rain thereafter. In some experiments, skin in- 
jection sites were immersed in paraformaldehyde-gluaraldehyde, 
cut into small pieces, and fixed for 1-4 h at room temperature (8). 
Alternatively, fixation  was  accomplished by  peffusing  animals 
with  paraformaldehyde-glutaraldehyde through  the  aorta.  Rat 
cremaster muscle was harvested and fixed as described (9). After 
fixation, tissues were processed for electron microscopy (8). 
A  total of 2,190  blocks of tissue was studied by electron mi- 
croscopy.  Electron  microscopic  sections  were  cut  at  dirt?rent 
thicknesses for  different purposes: standard  silver-gold (70-nm) 
sections for routine viewing; ultrathin (14-nm-thick) serial sec- 
tions for tracing connections between adjacent VVO vesicles and 
vacuoles and for preparing computer-aided three-dimensional re 
constructions;  and  serial  100-nm  sections  for  determining the 
dimensions and composition of individual VVOs in venular en- 
dothelium.  Data  were  analyzed  with  the  Mann-Whitney  or 
Kmskal-Wallis multiple comparison test. as appropriate. 
Results and Discussion 
WOs  were prominent in the largely continuous endo- 
thelium  that  lined  venules  of normal  flank  skin  of mice 
(Fig.  1 A), rats,  and  guinea pigs;  moreover,  their appear- 
ance  and  frequency were  identical with  both  methods  of 
tissue fixation. Like other plasma proteins,  circulating fer- 
ritin was largely retained within the microvessels of normal 
skin. However, ferritin extravasated extensively at sites in- 
jected with VPF (guinea pigs, mice, rats), histamine (guinea 
pigs),  or serotonin  (mice).  Within  seconds  of intradermal 
injection of these mediators, and continuing for some min- 
utes  thereafter,  increasing  amounts  of circulating  ferritin 
entered VVO  vesicles contiguous with the venular lumen 
and proceeded across the endothelium through a succession 
of interconnecting WO  vesicles and vacuoles to reach the 
vascular ablumen and underlying basal lamina (Fig. 1, B-E). 
Frequently, the stomata connecting adjacent VVO  vesicles 
and vacuoles to one another and to the luminal and ablu- 
minal plasma membranes  were  open  and  did not seem  to 
restrict ferritin passage (Fig. 1 C). Other stomata, however, 
were  closed by thin  diaphragms  (Fig.  1  E);  ferritin mole- 
cules sometimes accumulated in vesicles or vacuoles proxi- 
mal to such diaphragms, suggesting that diaphragms served 
as  a  barrier that  limited  their  further  transcellular passage 
(Fig.  1  E).  Interendothelial cell junctions  remained  intact 
(Fig.  1, J  and K)  and ferritin was never observed in junc- 
tions or free in endothelial cell cytoplasm. 
To quantitate the passage of ferritin across venules under 
different circumstances, we counted individual ferritin mole- 
cules  per  square  micrometer  in  representative,  randomly 
selected electron micrographs of normal mouse  flank skin 
or  of mouse  flank skin  injected  with  VPF,  serotonin,  or 
HBSS.  Ferritin concentrations  were  determined in venule 
plasma, in VVOs, and in the basal lamina immediately sub- 
jacent to WOs  (Table 1).  5 man after intradermal injection 
of VPF or serotonin, ferritin concentration in VVOs and in 
Figure 1.  Electron micrographs of venules from mouse or guinea pig skin (A-K) or from rat cremaster (L). As indicated, ferritin or colloidal carbon 
was injected intravenously, followed immediately by local injection of 12.5-100 ng VPF. Tissues were harvested 5 rain later. (A) Venule in normal 
mouse skin illustrating five distinct WOs (arrows) in the cytoplasm of a single endothelial cell. (B-E) VPF injection sites in guinea pig skin illustrating 
progressive extravasation of circulating ferritin from plasma across venular endothelium via WOs. (/3) Ferritin particles (black dots) in plasma. (C) A suc- 
cession of ferritin-containing VVO vesicles  and vacuoles at mid-level of endothelial cell cytoplasm. (D) Ferritin particles in subjacent extraceUular  matrix. 
(E) WO with ferritin-containing vesicles  and vacuoles. Ferritin is present in several vesicles  that open to the vascular  lumen or are separated from it by 
thin diaphragms. Two vesicles (*) in continuity with the abluminal plasma membrane do not contain ferritin but exhibit stomata closed by diaphragms. 
One starred vesicle (left)  is also separated by a diaphragm from a more proximal (more luminal) vacuole that contains numerous ferritin particles; micro- 
graphs such as this suggest that stomatal diaphragms represent barriers that restrict the transcellular  passage ofmacromolecules. Scattered ferritin particles 
are also present in the underlying basal lamina, several of which are indicated by arrows. (F-/) Four (ofa set of 36) consecutive serial ultrathin (14 nm) 
sections illustrate two sequences of interconnecting VVO vesicles-vacuoles  (a-d; e-  0 that traverse venule endothelial cell cytoplasm from vascular  lumen 
1982  Vesiculo-Vacuolar Organelles and Venular Permeability Regulation to ablumen.  (J, K) Two consecutive serial ultrathin sections of a single VVO. Three sequences of interconnecting vesicles-vacuoles are illustrated, the 
most luminal of  which are designated x, y, and z; each sequence nearly forms a transendothelial channel in just two consecutive sections. Note closed in- 
terendothelialjunction left of figure. (L) VPF-induced endothelial gap allows carbon extravasation from venule in rat cremaster muscle. L, lumen; R, red 
blood cell; BL, basal lamina; P, pericyte; and  W, Weibel-Palade body. A, ￿  B-D, X145,000;  E,  ￿  F-I, ￿  and K, ￿ 
and L, ￿  26,000.  (All magnifications are before 9.5% reduction.) Table 1.  Concentration  of Ferritin in  Venule Plasma, Venular Endothelial Cell VVOs, and Immediately Subjacent Subendothelial S'paa' ilt 
Normal Mouse Skin  Versus Skin Injected with  VPF, Serotonin, or HBSS 
Ferritin concentration (mean particles/l~m 2)  Percent plasma concentration 
Intradermal injection  Plasma  VVOs  Subendothelial space  VVOs  Subendothelial  space 
VPF  710  167  140  23.5  19.7 
Serotonin  670  121  129  18.1  19.3 
HBSS  690  59  38  8.6  5.5 
None  707  51  25  7.2  3.5 
A/J mice were injected intravenously with ferritin and intradermally with VPF, serotoniu, or HBSS as described in Materials and Methods. 5 rain 
later, mice were killed by CO  2  narcosis and skin test sites were fixed and processed for electron microscopy. A total of 78 venule sections were ana- 
lyzed in electron micrographs. Ferritin molecules were counted in plasma, in 365 separate WOs, and in the basal lamina immediately subjacent to 
VVOs. The areas of the several compartments counted were measured simultaneously so as to determine ferritin concentration (number of ferritin 
molecules/~,m2). Ferritin concentration in VVOs and subendothelial space at VPF and serotonin injection sites was significantly  greater than in ei- 
ther control site (p <0.001). 
the subjacent basal lamina was substantially greater than that 
at control sites  or at sites injected with HBSS. Thus, ferritin 
extravasates  minimally  from  normal  venules  by  way  of 
VVOs and mediators such as VPF and serotonin greatly in- 
crease ferritin extravasation by this route. 
VVOs are  three-dimensional  organel/es  and  their struc- 
ture  could  not be  fully appreciated  in individual  electron 
microscopic  sections.  Moreover,  standard  70-nm  sections 
were  too  thick  for  reliably  tracing  the  connections  that 
linked individual vesicles and vacuoles to one another and 
to the plasma membrane. Therefore, we prepared serial ul- 
trathin  14-nm sections of VPF-injected and control mouse 
skin.  Study of 38 such sets  of serial ultrathin sections,  each 
comprised of 9-61 serial sections, revealed a network of in- 
terconnecting  vesicles  and  vacuoles  and  established  that 
VVOs  formed  continuous  pathways  across venular  endo- 
thelium  from lumen  to ablumen  (Fig.  1,  F-K).  Serial  ul- 
trathin  sections  also  permitted  computer-assisted  three- 
dimensional reconstructions of individual WOs  from both 
VPF-injected  (Fig.  2)  and  normal  skin.  These  confirmed 
that the vesicles and vacuoles comprising WOs  intercon- 
nected to form serpentine  pathways that traversed venular 
endothelium  and  opened to both the lumen and ablumen 
at multiple sites. 
Morphometric measurements revealed that VVOs occu- 
pied a substantial  portion  (16-18%)  of venular endothelial 
cell  cytoplasm  in  both  normal  and  VPF-injected  mouse 
skin.  Individual  WOs  commonly extended  through  en- 
dothelial cell cytoplasm for distances of 1-2 I~m.  Based on 
52 sets  of serial  100-urn-thick sections  (each set comprised 
of 9-115  sequential  sections),  single WOs  were found to 
be  comprised  of 79-362  individual  vesicles  or  vacuoles 
(median,  124).  Smaller  VVO  vesicles  resembled  capillary 
caveolae (8,  10-12). However, taken together,  the vesicles 
and  vacuoles  comprising  VVOs  measured  108  -+  32  nm 
(mean  +  SD, range: 50--415 nm) in internal  diameter and 
were therefore significantly larger and more heterogeneous 
than capillary caveolae whose diameters measured, on aver- 
age, only 58 -+ 9 nm (range: 38-141  nm, p  <0.01)  (Fig. 3). 
Thus,  the  vesicles  and  vacuoles  comprising  VVOs  differ 
from the  caveolae of capillary endothelium  in  several  im- 
portant  respects:  significantly  larger  average  size,  greater 
size  heterogeneity,  and  organization  into  a  cohesive  or- 
ganelle (the VVO) that occupies nearly one fifth ofvenular 
endothelial cell cytoplasm and that links the vascular lumen 
with the abhimen.  The large size and complexity of VVOs 
suggest that they are sessile structures and that their compo- 
nent vesicles and vacuoles are unlikely to shuttle back and 
forth across endothelial  cytoplasm as has been proposed for 
capillary caveolae  (10,  11).  VVOs  resemble  the  vesicular- 
vacuolar networks  that have  been  described  in amphibian 
capillary cytoplasm  (13,  14),  but,  as shown here,  differ in 
that VVOs traverse  the  entire  thickness  of endothelial  cell 
cytoplasm, opening to both lumen and ablumen,  and have 
a prominent role in macromolecule extravasation. 
Earlier  investigators,  including  ourselves,  had  reported 
that VPF and inflammatory mediators, such as histamine or 
serotonin,  increased  venular permeability  by inducing the 
formation of interendothelial  gaps (9,  15-18). However, in 
our present  experiments  with  ferritin  as  tracer,  gaps  were 
exceedingly rare  (<1  per  2,000 junctions  studied).  In at- 
tempting  to  explain  this  difference,  we  noted  that,  with 
one exception  (19),  studies demonstrating endothelial  gaps 
had used colloidal particulates (carbon or Monastral blue) as 
tracers.  To  determine  whether  gap  formation  might  de- 
pend on physical properties (e.g., size,  particulate nature)  of 
the  tracer,  we performed permeability studies  with  colloi- 
dal carbon as tracer instead of ferritin.  In contrast to our re- 
sults  with  ferritin,  we  found  frequent  venular  endothelial 
gaps  through  which  carbon  extravasated  at  sites  of VPF 
(Fig.  1  K)  or histamine  injection.  Carbon  particles  were 
only rarely found in VVOs and were, on average, too large 
to pass through the stomata that interconnected VVO vesi- 
cles  and  vacuoles  with  one  another  and  with  the  plasma 
membrane. These findings suggest that endothelial gap for- 
mation is related,  at least in part,  to properties of the tracer 
1984  Vesiculo-Vacuolar Organelles and Venular Permeability Regulation Figure 2.  Computer-generated three-dimensional  reconstruction of portion of a venular VVO from mouse skin injected 5 rain earlier with 50 ng 
VPF. The interior volumes of VVO vesicles and vacuoles in successive electron micrographs were traced onto transparent  overlays with reference marks 
to retain register. Tracings  were digitized  at a resolution  of 5.9 nm/pixel. Since  section  thickness (15 nm) was greater than in-plane resolution,  bicubic in- 
terpolation was performed between sections and convolutions  were used to smooth surfaces. (A-F) Portion of a VVO (15 consecutive  serial, ultrathin 
electron microscopy sections illustrating  25 individual  vesicles-vacuoles)  reconstructed with Advanced Visual Systems (Waltham, MA) software, here 
viewed in successive  rotations  around a horizontal  axis at intervals  of 30  ~ (except 15  ~ C and D). There are two openings (E and F) to the vascular  lumen 
and four to the abluminal  surface (A). 
itself; i.e.,  that particulate tracers  such as  colloidal carbon 
interact with endothehum to induce gap formation at test 
sites injected with VPF or inflammatory mediators. 
In summary, we  have  identified VVOs  as  the  primary 
anatomic pathway by which ferritin, a  physiological pro- 
tein  useful  for  measuring  bulk  transport,  exits  normal 
venules in response to VPF, histamine, and serotonin. Pre- 
sumably, other plasma proteins also exit venules by way of 
VVOs.  Our data are consistent with the view that the hy- 
perpermeabihty characteristic  of tumor microvessels is at- 
tributable  to  upregulation of VVO  function by  tumor- 
secreted VPF and with immunocytochemical  evidence that 
has localized VPF  to  VVOs  in tumor vessel endothelium 
(20).  Remaining to  be  worked  out  are  the  molecular 
mechanisms by which VPF or inflammatory mediators in- 
teract with specific endothelial receptors to activate VVO 
function. The  stomata  that  link individual VVO  vesicles 
and vacuoles to one another and to the plasma membranes 
are  often  closed by thin diaphragms similar to  those  that 
close capillary caveolae (10,  11). We suggest that VPF and 
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other mediators that increase venule permeability provoke 
the  opening  of these  diaphragms,  whether  physically or 
functionally, to allow trans-endothelial  cell passage of mac- 
romolecules.  Also  remaining  to  be  investigated  are  the 
mechanisms  by  which  colloidal carbon  and  likely  other 
particulates  interact  with  venular  endothelium,  together 
with VPF or inflammatory mediators, to induce the forma- 
tion of endothelial gaps. 
Figure 3.  Size  distribution of vesicles and vacuoles comprising VVOs 
(n =  1,657) in venular endothelium compared with caveolae (n =  1,225) 
of capillary endothelium. Data from normal uninjected mouse skin and 
mouse skin injected 5 rain  earlier  with  VPF did not differ and were 
pooled. Venules were distinguished from capillaries  according to Simion- 
escu (11). 
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